Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: Reference to pharmacokinetic properties of dendrimer-based MR contrast agents

Journal of Magnetic Resonance Imaging

Volumn 14, Issue 6, 2001, Pages 705-713

  Kobayashi, Hisataka ^a   Kawamoto, Satomi ^a,b   Saga, Tsuneo ^a   Sato, Noriko ^a   Hiraga, Akira ^a   Konishi, Junji ^a   Togashi, Kaori ^a   Brechbiel, Martin W ^c  

^a KYOTO UNIVERSITY   (Japan)

^b OTSU MUNICIPAL HOSPITAL   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Contrast media; Dendrimers; Magnetic resonance imaging; MR angiography; Pharmacokinetics

Indexed keywords

2 (4 ISOTHIOCYANATOBENZYL) 6 METHYLDIETHYLENETRIAMINEPENTAACETIC ACID; CONTRAST MEDIUM; DENDRIMER; GADOLINIUM PENTETATE; GENERATION 6 DENDRIMER; GENERATION 7 DENDRIMER; GENERATION 8 DENDRIMER; GENERATION 9 DENDRIMER; PENTETIC ACID DERIVATIVE; POLYAMIDOAMINE DENDRIMER; STARBURST POLYAMIDOAMINE DENDRIMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONFORMATION; DRUG DISTRIBUTION; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; KIDNEY CLEARANCE; LIVER CLEARANCE; MACROMOLECULE; MAGNETIC RESONANCE ANGIOGRAPHY; MICROANGIOGRAPHY; MOLECULAR SIZE; MOUSE; NONHUMAN; OPTICAL RESOLUTION; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ANALYSIS OF VARIANCE; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSELS; CELL LINE; CONTRAST MEDIA; GADOLINIUM DTPA; LIVER; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; MODELS, ANIMAL; MOLECULAR WEIGHT; POLYAMINES;

EID: 0035191513     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10025     Document Type: Article

References (30)

1. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter
2. Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging
3. Functional polymers and dendrimers: Reactivity, molecular architecture, and interfacial energy
4. Starburst dendrimers: Enhanced performance and flexibility for immunoassays
5. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy
6. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody
7. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
8. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on three-dimensional time of flight magnetic resonance angiography of the body
9. Three-dimensional-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties
10. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer
11. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores
12. Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody
13. Recognition of serum alkaline phosphatase by murine monoclonal antibodies against human osteosarcoma cells
14. A novel intravascular macromolecular MR contrast agent with generation-4 polyamidoamine dendrimer core: Accelerated renal excretion with coinjection of lysine
15. Three-dimensional MR angiography of intratumoral vasculature using a macromolecular MR contrast agent
16. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
17. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40
18. MR imaging of acute myocardial infarction in pigs using Gd-DTPA-labeled dextran
19. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues
20. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits
21. Gadolinium-labeled liposomes: Targeted MR contrast agents for the liver and spleen
22. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns
23. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies
24. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates
25. Three-dimensional-micro-MR angiography using macromolecular MR contrast agents with various size of polyamidoamine dendrimer cores
26. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
27. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
28. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
29. Tumoritropic and lymphotropic principles of macromolecular drugs
30. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs